Zifu Li Selected Research

Doxorubicin (Adriamycin)

5/2024	Softness-Aided Mild Hyperthermia Boosts Stiff Nanomedicine by Regulating Tumor Mechanics.
1/2023	Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy.
1/2023	Hydroxyethyl starch-folic acid conjugates stabilized theranostic nanoparticles for cancer therapy.
3/2017	Enhancing Doxorubicin Delivery toward Tumor by Hydroxyethyl Starch-g-Polylactide Partner Nanocarriers.
11/2016	Redox-Sensitive Hydroxyethyl Starch-Doxorubicin Conjugate for Tumor Targeted Drug Delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zifu Li Research Topics

Disease

40	Neoplasms (Cancer) 05/2024 - 11/2016
22	Ischemic Stroke 02/2024 - 01/2020
18	Stroke (Strokes) 02/2024 - 01/2016
7	Neoplasm Metastasis (Metastasis) 02/2024 - 08/2018
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2023 - 09/2020
5	Cerebral Infarction 10/2022 - 01/2016
4	Hypertension (High Blood Pressure) 10/2023 - 10/2022
4	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2021
3	Thrombosis (Thrombus) 02/2024 - 01/2019
3	Infarction (Infarctions) 11/2023 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 03/2019
3	Triple Negative Breast Neoplasms 01/2023 - 12/2021
3	Hypoxia (Hypoxemia) 01/2023 - 08/2018
3	Aneurysm (Aneurysms) 11/2017 - 09/2012
3	Neointima 11/2017 - 09/2012
2	Hyperthermia 05/2024 - 12/2022
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2024 - 01/2023
2	Hemorrhage 11/2023 - 01/2022
2	Hematoma 10/2023 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 01/2022
1	Intracranial Aneurysm (Cerebral Aneurysm) 02/2024
1	Brain Infarction 02/2024
1	Carcinogenesis 02/2024
1	Adenocarcinoma 01/2024
1	Cerebral Hemorrhage 11/2023
1	Atherosclerosis 10/2023
1	Fibrosis (Cirrhosis) 10/2023
1	Ureteral Obstruction 10/2023
1	IGA Glomerulonephritis (IGA Nephropathy) 10/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023

Drug/Important Bio-Agent (IBA)

13	Starch (Cornstarch)IBA 01/2023 - 11/2016
11	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2024 - 01/2020
8	Oxygen (Dioxygen)IBA 02/2024 - 08/2018
8	ProdrugsIBA 01/2023 - 11/2016
6	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2022
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2024 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2016
5	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 11/2016
5	Folic Acid (Vitamin M)FDA LinkGeneric 10/2023 - 09/2018
5	Nanoparticle Drug Delivery SystemIBA 01/2023 - 12/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 03/2019
4	Therapeutic UsesIBA 01/2023 - 03/2017
4	DisulfidesIBA 01/2023 - 01/2019
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2024 - 03/2019
3	NanogelsIBA 05/2024 - 12/2018
3	CopperIBA 01/2024 - 01/2023
3	Glutathione (Reduced Glutathione)IBA 01/2023 - 05/2021
3	Photosensitizing Agents (Photosensitizers)IBA 01/2023 - 01/2019
3	polydopamineIBA 04/2022 - 01/2019
3	CollagenIBA 06/2021 - 08/2018
3	Antineoplastic Agents (Antineoplastics)IBA 06/2020 - 11/2016
3	Pancreatic Elastase (Elastase)IBA 11/2017 - 09/2012
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2021
2	Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link 01/2024 - 01/2023
2	Tirofiban (Aggrastat)FDA Link 10/2023 - 10/2022
2	Peptides (Polypeptides)IBA 01/2023 - 01/2019
2	starch polycaprolactoneIBA 01/2023 - 12/2017
2	Long Noncoding RNAIBA 01/2022 - 02/2020
2	Biopolymers (Biopolymer)IBA 01/2022 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	liposomal doxorubicin (Doxil)FDA Link 01/2022 - 08/2018
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 03/2019
2	LY-2157299IBA 06/2021 - 10/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2021 - 01/2021
2	PlatinumIBA 03/2019 - 02/2018
2	poly(lactide) (polylactic acid)IBA 10/2018 - 03/2017
2	Messenger RNA (mRNA)IBA 11/2017 - 03/2017
1	nitinolIBA 02/2024
1	TNF Receptor-Associated Factor 1IBA 02/2024
1	Glutamic Acid (Glutamate)FDA Link 01/2024
1	InterferonsIBA 01/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	Antihypertensive Agents (Antihypertensives)IBA 12/2023
1	Blood Glucose (Blood Sugar)IBA 11/2023
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 11/2023
1	aristolochic acid I (aristolochic acid)IBA 10/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023
1	adavosertibIBA 01/2023
1	lonidamineIBA 01/2023
1	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 01/2023
1	erastinIBA 01/2023
1	olaparibIBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	AntioxidantsIBA 01/2023
1	CarbamatesIBA 01/2023
1	EnzymesIBA 01/2023
1	Glucose OxidaseIBA 01/2023
1	IodidesIBA 01/2023
1	IonsIBA 01/2023

Therapy/Procedure

28	Therapeutics 02/2024 - 12/2017
24	Thrombectomy 02/2024 - 01/2020
12	Drug Therapy (Chemotherapy) 01/2023 - 11/2016
8	Photochemotherapy (Photodynamic Therapy) 01/2023 - 01/2019
4	Lasers (Laser) 12/2022 - 03/2019
4	Stents 01/2021 - 02/2014
3	Photothermal Therapy 05/2024 - 01/2021
3	Precision Medicine 01/2023 - 02/2018
2	Punctures 01/2021 - 09/2020
1	Ligation 02/2024
1	Anesthesia 07/2023